A paradoxical reduction in susceptibility to colonic injury upon targeted transgenic ablation of goblet cells
Open Access
- 1 December 1999
- journal article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 104 (11) , 1539-1547
- https://doi.org/10.1172/jci6211
Abstract
Goblet cells are the major mucus-producing cells of the intestine and are presumed to play an important role in mucosal protection. However, their functional role has not been directly assessed in vivo. In initial studies, a 5′ flanking sequence of the murine intestinal trefoil factor (ITF) gene was found to confer goblet cell–specific expression of a transgene. To assess the role of goblet cells in the intestine, we generated transgenic mice in which ∼60% of goblet cells were ablated by the expression of an attenuated diphtheria toxin (DT) gene driven by the ITF promoter; other cell lineages were unaffected. We administered 2 exogenous agents, dextran sodium sulfate (DSS) and acetic acid, to assess the susceptibility of mITF/DT-A transgenic mice to colonic injury. After oral administration of DSS, 55% of control mice died, whereas DT transgenic mice retained their body weight and less than 5% died. Similarly, 30% of the wild-type mice died after mucosal administration of acetic acid, compared with 3.2% of the transgenic mice. Despite the reduction in goblet-cell number, the total amount of ITF was increased in the mITF/DT-A transgenic mice, indicating inducible compensatory mechanisms. These results suggest that goblet cells contribute to mucosal protection and repair predominantly through production of trefoil peptides. J. Clin. Invest.104:1539–1547 (1999).Keywords
This publication has 47 references indexed in Scilit:
- Identification of a Goblet Cell-specific Enhancer Element in the Rat Intestinal Trefoil Factor Gene Promoter Bound by a Goblet Cell Nuclear ProteinPublished by Elsevier ,1998
- Impaired Defense of Intestinal Mucosa in Mice Lacking Intestinal Trefoil FactorScience, 1996
- MUC2 is the prominent colonic mucin expressed in ulcerative colitis.Gut, 1996
- Experimental ulceration leads to sequential expression of spasmolytic polypeptide, intestinal trefoil factor, epidermal growth factor and transforming growth factor alpha mRNAs in rat stomachThe Journal of Pathology, 1995
- Spontaneous development of inflammatory bowel disease in T cell receptor mutant miceCell, 1993
- Interleukin-10-deficient mice develop chronic enterocolitisCell, 1993
- Ulcerative colitis-like disease in mice with a disrupted interleukin-2 geneCell, 1993
- Intestinal epithelial differentiation: new insights from chimeric and transgenic mice.The Journal of cell biology, 1989
- The Role of Mucus in the Protection of the Gastroduodenal MucosaScandinavian Journal of Gastroenterology, 1986
- Experimental Production of Diffuse Colitis in RatsDigestion, 1978